Confirmed speakers:

  • Prof. Dr. Barbara Burwinkel
    Head of Molecular Epidemiology Department, German Cancer Research Center (DKFZ), Heidelberg, Germany
  • Prof. Dr. Oliver Fiehn
    Director, NIH West Coast Metabolomics Center, University of California, Davis, USA
  • Prof. Dr. Carsten Grüllich
    Head of Translational Uro-Oncology Department, National Center for Tumor Diseases, Heidelberg, Germany
  • Prof. Dr. Stephan Herzig
    Director, Institute for Diabetes and Cancer, Helmholtz Zentrum München, Munich, Germany
  • Prof. Dr. Karsten Hiller
    Head of Department of Bioinformatics and Biochemistry, Technical University Braunschweig, Germany
  • Prof. Dr. Carsten Hopf
    Director of Center for Biomedical Mass Spectrometry and Optical Spectroscopy, University Medical Centre Mannheim, Mannheim, Germany
  • Prof. Dr. Hector Keun
    Head of Cancer Metabolism and Systems Toxicology Group, Imperial College London, UK
  • Dr. Therese Koal
    Director, Research and Development, Biocrates Life Sciences AG, Innsbruck, Austria
  • Dr. Augustin Scalbert
    Head of Biomarkers Group, International Agency for Research on Cancer (WHO), Lyon, France
  • Prof. Dr. Almut Schulze
    Head of Department of Biochemistry and Molecular Biology, University of Würzburg, Germany
  • Prof. Dr. Aurelio Teleman
    Head of Signal Transduction in Cancer and Metabolism Department, German Cancer Research Center (DKFZ), Heidelberg, Germany